Related Experiment Video
Updated: Dec 14, 2025

Activating Autophagy by Aerobic Exercise in Mice
Published on: February 3, 2017
Application of Autophagy in Cardiovascular Diseases
Jie Du1, Yulin Li2, Congcong Zhang2
1Beijing Anzhen Hospital Affiliated with Capital Medical University, Beijing, China. jiedubj@126.com.
Insights
Autophagy, a cellular process, is linked to cardiovascular disease development. Modulating autophagy with activators or inhibitors shows promise as a novel therapeutic strategy for heart conditions.
Area of Science:
- Biochemistry
- Molecular Biology
- Cardiovascular Medicine
Background:
- Autophagy plays a critical role in cellular homeostasis and stress response.
- Dysregulation of autophagy is implicated in the pathogenesis and progression of various cardiovascular diseases, including heart failure and atherosclerosis.
- Understanding the intricate mechanisms of autophagy is crucial for developing effective cardiovascular therapies.
Purpose of the Study:
- To review the current literature on the role of autophagy in cardiovascular diseases.
- To summarize the potential of autophagy modulators (activators and inhibitors) as therapeutic agents for cardiovascular conditions.
- To provide an overview of key autophagy pathways relevant to cardiovascular health and disease.
Main Methods:
- Literature review of preclinical and clinical studies on autophagy and cardiovascular diseases.
- Analysis of experimental data on the effects of autophagy activators and inhibitors in cardiovascular models.
- Synthesis of information regarding the molecular targets and mechanisms of autophagy modulation in the context of heart disease.
Main Results:
- Autophagy is a double-edged sword in cardiovascular disease, with context-dependent roles.
- Pharmacological activation or inhibition of autophagy can exert protective or detrimental effects on the cardiovascular system.
- Specific autophagy pathways are associated with distinct cardiovascular pathologies, offering targeted therapeutic opportunities.
Conclusions:
- Autophagy represents a promising, yet complex, therapeutic target for cardiovascular diseases.
- Further research is needed to elucidate the precise roles of different autophagy pathways in specific cardiovascular conditions.
- Development of selective autophagy modulators holds potential for novel cardiovascular drug discovery.
Abstract:
Autophagy is closely related to the pathogenesis and progression of cardiovascular diseases. Autophagy may be a therapeutic target for many cardiovascular diseases. In this chapter, we will summarize autophagy activators and inhibitors as potential drugs for cardiovascular diseases.
Related Concept Videos
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Pathophysiology of Heart Failure
Cardiomyopathy V: Interprofessional Care
Cardiovascular Drugs: Classification based on Therapeutic Indications

